Ruane, Cunniff & Goldfarb
Sequoia Fund
Sequoia Fund Eurofins Scientific SE stake
total: 59
Sequoia Fund ERFSF trades
- Total transactions:
- 13
- New positions:
- 1
- Added:
- 5
- Reduced:
- 7
- Held since:
- 2019 Q4
- Held for:
- 26 quarters
- Latest activity:
- 2025 Q4
According to 2026 Q1 report, Sequoia Fund holds 2,921,395 Eurofins Scientific SE (ERFSF) shares with a market value of roughly $211.58M accounting for 6.52% of the overall portfolio. To date, the estimated cost basis is nearly $104.57 for "buy" trades and estimated average "sell" price is $101.84. Sequoia Fund first purchased ERFSF in 2019 Q4, initially acquiring 232,437 shares. Since the initial investment in Eurofins Scientific SE (ERFSF), Sequoia Fund has made 12 more transactions.
When did Sequoia Fund buy Eurofins Scientific SE (ERFSF)?
Sequoia Fund first invested in Eurofins Scientific SE (ERFSF) in 2019 Q4 at the reported quarter-end price of $554.35 per share.
What's the cost basis of Sequoia Fund's ERFSF stake?
The estimated cost basis for Eurofins Scientific SE (ERFSF) stake is around $104.57 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $104.57
- Weighted AVG sell price:
- $101.84
Sequoia Fund's historical trades in Eurofins Scientific SE
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q4
|
5.88%
|
2,921,395
|
$73.33
|
$214,233,140
|
-0.16% (-4,668)
|
-0.01%
|
|
2024 Q4
|
4.61%
|
2,926,063
|
$51.08
|
$149,456,754
|
+17.74% (+440,908)
|
+0.7%
|
|
2023 Q3
|
4.94%
|
2,485,155
|
$56.56
|
$140,567,512
|
-2.70% (-69,057)
|
-0.13%
|
|
2022 Q4
|
6.30%
|
2,554,212
|
$71.78
|
$183,352,517
|
+32.81% (+630,939)
|
+1.56%
|
|
2022 Q3
|
4.07%
|
1,923,273
|
$59.90
|
$115,205,314
|
+27.52% (+415,107)
|
+0.88%
|
|
2021 Q4
|
3.85%
|
1,508,166
|
$123.87
|
$186,814,713
|
-4.47% (-70,617)
|
-0.18%
|
|
2021 Q2
|
3.78%
|
1,578,783
|
$114.31
|
$180,464,843
|
-15.94% (-299,394)
|
-0.74%
|
|
2021 Q1
|
3.89%
|
1,878,177
|
$95.59
|
$179,528,886
|
-16.87% (-381,213)
|
-0.86%
|
|
2020 Q4
|
4.46%
|
$83.84
|
+871.48% (+2,026,819)
|
|||
|
2020 Q3
|
4.72%
|
$791.88
|
-0.19% (-452)
|
|||
|
2020 Q2
|
4.12%
|
$627.58
|
-0.04% (-87)
|
|||
|
2020 Q1
|
3.99%
|
$497.41
|
+0.29% (+673)
|
|||
|
2019 Q4
|
3.37%
|
$554.35
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.